Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.

Literature DB >> 21690502

Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.

Camille E Powe¹, Richard J Levine, S Ananth Karumanchi.

Abstract

Entities: Chemical

Mesh：

Year: 2011 PMID： 21690502 PMCID： PMC3148781 DOI： 10.1161/CIRCULATIONAHA.109.853127

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

191 in total

1. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?

Authors: Alfredo M Germain; Mary Carmen Romanik; Irene Guerra; Sandra Solari; María Soledad Reyes; Richard J Johnson; Karen Price; S Ananth Karumanchi; Gloria Valdés
Journal: Hypertension Date: 2006-11-20 Impact factor: 10.190

Review 2. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

Authors: S Thangaratinam; K M K Ismail; S Sharp; A Coomarasamy; K S Khan
Journal: BJOG Date: 2006-04 Impact factor: 6.531

3. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

Authors: Y Zhou; C H Damsky; S J Fisher
Journal: J Clin Invest Date: 1997-05-01 Impact factor: 14.808

4. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Authors: Tomomi Kamba; Betty Y Y Tam; Hiroya Hashizume; Amy Haskell; Barbara Sennino; Michael R Mancuso; Scott M Norberg; Shaun M O'Brien; Rachel B Davis; Lori C Gowen; Keith D Anderson; Gavin Thurston; Shuji Joho; Matthew L Springer; Calvin J Kuo; Donald M McDonald
Journal: Am J Physiol Heart Circ Physiol Date: 2005-09-19 Impact factor: 4.733

Review 5. Role of angiogenesis in cardiovascular disease: a critical appraisal.

Authors: Rohit Khurana; Michael Simons; John F Martin; Ian C Zachary
Journal: Circulation Date: 2005-09-20 Impact factor: 29.690

6. Renin, angiotensin and aldosterone relationships in normal pregnancy.

Authors: R J Weir; D B Paintin; J I Robertson; M Tree; R Fraser; J Young
Journal: Proc R Soc Med Date: 1970-11

7. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.

Authors: Akihide Ohkuchi; Chikako Hirashima; Hirotada Suzuki; Kayo Takahashi; Mika Yoshida; Shigeki Matsubara; Mitsuaki Suzuki
Journal: Hypertens Res Date: 2010-02-12 Impact factor: 3.872

8. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors: Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal: Nat Med Date: 2002-07-01 Impact factor: 53.440

9. Maternal hypoxia activates endovascular trophoblast cell invasion.

Authors: Gracy X Rosario; Toshihiro Konno; Michael J Soares
Journal: Dev Biol Date: 2007-12-15 Impact factor: 3.582

10. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study.

Authors: Richard J Levine; Lars J Vatten; Gary L Horowitz; Cong Qian; Pal R Romundstad; Kai F Yu; Anthony N Hollenberg; Alf I Hellevik; Bjorn O Asvold; S Ananth Karumanchi
Journal: BMJ Date: 2009-11-17

253 in total

1. VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.

Authors: Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi
Journal: Mol Cell Biochem Date: 2017-08-02 Impact factor: 3.396

2. Hemodynamic, vascular, and reproductive impact of FMS-like tyrosine kinase 1 (FLT1) blockade on the uteroplacental circulation during normal mouse pregnancy.

Authors: Eliyahu V Khankin; Maurizio Mandala; Ilsley Colton; S Ananth Karumanchi; George Osol
Journal: Biol Reprod Date: 2012-02-29 Impact factor: 4.285

3. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta.

Authors: Wen Wang; Lin Feng; Honghai Zhang; Stephanie Hachy; Seiro Satohisa; Louise C Laurent; Mana Parast; Jing Zheng; Dong-bao Chen
Journal: J Clin Endocrinol Metab Date: 2012-03-21 Impact factor: 5.958

4. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors: B Lamarca
Journal: Minerva Ginecol Date: 2012-08

5. Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors: Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2017-12-06 Impact factor: 3.619

6. Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity.

Authors: Philippe Vangrieken; Alex H V Remels; Salwan Al-Nasiry; Aalt Bast; Ger M J Janssen; Ulrike von Rango; Daan Vroomans; Yannick C W Pinckers; Frederik J van Schooten; Paul M H Schiffers
Journal: Hypertens Res Date: 2020-07-30 Impact factor: 3.872